About BioLegend
Founded in 2002, BioLegend develops antibodies, recombinant proteins, assay kits and proteogenomics reagents for life science research and translational applications. The company specialises in technologies that support cellular analysis, immune profiling and biomarker discovery across immunology, oncology, neuroscience, stem cell biology and clinical research. BioLegend’s expertise spans flow cytometry, immunoassays and single-cell analysis, providing researchers with tools to investigate cell phenotype, function and molecular mechanisms. Its platforms support applications including flow cytometry, ELISA, immunohistochemistry, immunofluorescence, western blotting and proteogenomics workflows, enabling detailed characterisation of complex biological systems.
The company’s portfolio includes thousands of antibodies and fluorophore conjugates, recombinant proteins, multiplex assay kits and cell separation reagents. Notable product families include TotalSeq™ oligo-conjugated antibodies for single-cell proteogenomics, MojoSort™ cell isolation reagents, Flexi-Fluor™ reagents and a broad range of flow cytometry tools built around proprietary fluorophore technologies. BioLegend products are widely used for immune monitoring, cancer research, stem cell analysis, neuroscience research and biomarker development, supporting workflows from basic discovery through translational and clinical research.
Europa Biosite’s subsidiaries distribute for BioLegend in Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway and Sweden.